Immune checkpoint inhibitor-associated electrolyte disorders: query of the Food and Drug Administration Adverse Event Reporting System

被引:10
作者
Wanchoo, Rimda [1 ]
Sakhiya, Vipulbhai [1 ]
Jhaveri, Kenar D. [1 ]
机构
[1] Donald & Barbara Zucker Sch Med Hofstra Northwell, Div Kidney Dis & Hypertens, 100 Community Dr, Great Neck, NY 11021 USA
关键词
D O I
10.1016/j.kint.2021.06.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:945 / 947
页数:3
相关论文
共 4 条
  • [1] Immune checkpoint inhibitor-associated hypercalcaemia
    Izzedine, Hassan
    Chazal, Thibaud
    Wanchoo, Rimda
    Jhaveri, Kenar D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (09) : 1598 - 1608
  • [2] Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System
    Jhaveri, Kenar D.
    Sakhiya, Vipulbhai
    Wanchoo, Rimda
    Ross, Daniel
    Fishbane, Steven
    [J]. KIDNEY INTERNATIONAL, 2016, 90 (03) : 706 - 707
  • [3] Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis
    Manohar, Sandhya
    Kompotiatis, Panagiotis
    Thongprayoon, Charat
    Cheungpasitporn, Wisit
    Herrmann, Joerg
    Herrmann, Sandra M.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (01) : 108 - 117
  • [4] Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors
    Seethapathy, Harish
    Rusibamayila, Nifasha
    Chute, Donald F.
    Lee, Meghan
    Strohbehn, Ian
    Zubiri, Leyre
    Faje, Alexander T.
    Reynolds, Kerry L.
    Jhaveri, Kenar D.
    Sise, Meghan E.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (12) : 2241 - 2247